Live Breaking News & Updates on Lubiprostone Capsules

Stay updated with breaking news from Lubiprostone capsules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr. Reddy's Q4 & FY23 Financial Results

Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2023. The information mentioned in this release is on the. | May 10, 2023 ....

United Kingdom , United States , Hong Kong , Exchange Commission , Nimbus Health Gmb , Drug Administration , Indivior Inc , International Toll Free Number , Aquestive Therapeutics Inc , Reddy Laboratories , International Financial Reporting Standards , Reddy Laboratories Ltd , Indivior United Kingdom , Business Wire , Laboratories Limited , Earnings Per Share , Active Ingredients , North America , Emerging Markets , North America Generics , Lurasidone Tablets , Lubiprostone Capsules , Sunitinib Capsules , Nelarabine Injection , Abbreviated New Drug Applications , Statement Highlights ,

Dr Reddy's Q4FY23 consolidated PAT jumps 996 pc YoY to Rs 959 cr | Indiablooms - First Portal on Digital News Management

Hyderabad: Hyderabad-based Pharma giant Dr Reddy’s Lab on Wednesday reported a consolidated net profit of Rs 959 crore for the fourth quarter ended March 2023, up 996 percent over Rs 87.5 crore reported in the corresponding quarter in the previous year. ....

United States , Managing Directorgv Prasad , North America , Lurasidone Tablets , Lubiprostone Capsules , Sunitinib Capsules , Nelarabine Injection , Pharmaceutical Services , Active Ingredients , Yderabad Hyderabad Based Pharma Giant Dr Reddy Rsquos Lab On Wednesday Reporteda Consolidated Net Profit Of Rs 959 Crore For The Fourth Quarter Ended March 2023 , P 996 Percent Over Rs 87 5 Crore Reported In The Corresponding Quarter Previous Year ,

Zydus receives Final Approval from the USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg

Zydus Lifesciences Limited has received final approval for Lubiprostone Capsules, 8 mcg and 24 mcg from the United States Food and Drug Administration. ....

United States , Drug Administration , Zydus Lifesciences , Final Approval , Lubiprostone Capsules , Lifesciences Limited , United States Food , Zydus Lifesciences Limited ,

Nifty, Sensex Down For the Second Session on Tax on Debt Fund, Global Cues- Friday Closing Report

On the Bombay Stock Exchange (BSE), 1037 stocks advanced, 2454 declined and 139 remained unchanged with advance decline ratio of 0.42, indicating a negative closing of stocks in broader markets. ....

Akg Exim , Asian Energy Services , Bharat Electronics , Ashiana Housing Ltd , Bajaj Holdings , Ministry Of Defence , Karur Vysya Bank , Bombay Stock Exchange , Haryana State Industrial Infrastructure Development Corporation , Lal Path Labs Ltd , Chalet Hotels , Life Insurance Company Ltd , Nifty Media , Nifty Metal , Nifty Infrastructure , Integrated Electronic Warfare Systems , Sponge Iron Plant , State Industrial , Infrastructure Development Corporation , Lubiprostone Capsules , Vysya Bank , Insurance Company Ltd , Hotels Limited , Dukes Retreat , Obeticholic Acid , Zydus Wellness ,